Literature DB >> 28887905

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

J A Obeso1,2,3, M Stamelou4,5, C G Goetz6, W Poewe7, A E Lang8,9, D Weintraub10,11, D Burn12, G M Halliday13,14, E Bezard15,16, S Przedborski17,18, S Lehericy19,20, D J Brooks21,22, J C Rothwell23, M Hallett24, M R DeLong25, C Marras26, C M Tanner27,28, G W Ross29, J W Langston30, C Klein31, V Bonifati32, J Jankovic33, A M Lozano34, G Deuschl35, H Bergman36,37,38, E Tolosa39,40, M Rodriguez-Violante41,42, S Fahn43, R B Postuma44, D Berg45, K Marek46, D G Standaert47, D J Surmeier48, C W Olanow49, J H Kordower50,51, P Calabresi52,53, A H V Schapira54, A J Stoessl55,56.   

Abstract

This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he described accurately and what he missed from today's perspective. Parkinson's disease today is understood as a multietiological condition with uncertain etiopathogenesis. Many advances have occurred regarding pathophysiology and symptomatic treatments, but critically important issues are still pending resolution. Among the latter, the need to modify disease progression is undoubtedly a priority. In sum, this multiple-author article, prepared to commemorate the bicentenary of the shaking palsy, provides a historical state-of-the-art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  200 years anniversary; Parkinson's disease; Shaking Palsy

Mesh:

Year:  2017        PMID: 28887905      PMCID: PMC5685546          DOI: 10.1002/mds.27115

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  285 in total

1.  A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus.

Authors:  D Plenz; S T Kital
Journal:  Nature       Date:  1999-08-12       Impact factor: 49.962

2.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

Authors:  J H Kordower; M E Emborg; J Bloch; S Y Ma; Y Chu; L Leventhal; J McBride; E Y Chen; S Palfi; B Z Roitberg; W D Brown; J E Holden; R Pyzalski; M D Taylor; P Carvey; Z Ling; D Trono; P Hantraye; N Déglon; P Aebischer
Journal:  Science       Date:  2000-10-27       Impact factor: 47.728

Review 3.  Complex I and Parkinson's disease.

Authors:  J T Greenamyre; T B Sherer; R Betarbet; A V Panov
Journal:  IUBMB Life       Date:  2001 Sep-Nov       Impact factor: 3.885

4.  Risk of dementia in Parkinson's disease: a community-based, prospective study.

Authors:  D Aarsland; K Andersen; J P Larsen; A Lolk; H Nielsen; P Kragh-Sørensen
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

5.  A Drosophila model of Parkinson's disease.

Authors:  M B Feany; W W Bender
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

6.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

Authors:  E Masliah; E Rockenstein; I Veinbergs; M Mallory; M Hashimoto; A Takeda; Y Sagara; A Sisk; L Mucke
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

7.  Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism.

Authors:  A Raz; E Vaadia; H Bergman
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 8.  Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?

Authors:  K A Jellinger
Journal:  J Neural Transm Suppl       Date:  1999

9.  Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease.

Authors:  J H Kordower; S Palfi; E Y Chen; S Y Ma; T Sendera; E J Cochran; E J Cochran; E J Mufson; R Penn; C G Goetz; C D Comella
Journal:  Ann Neurol       Date:  1999-09       Impact factor: 10.422

Review 10.  Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back.

Authors:  Hagai Bergman; Günther Deuschl
Journal:  Mov Disord       Date:  2002       Impact factor: 10.338

View more
  185 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  Saul Martinez-Horta; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2019-04-08       Impact factor: 3.575

2.  DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1.

Authors:  Yi Liu; Xiaopin Ma; Hisashi Fujioka; Jun Liu; Shengdi Chen; Xiongwei Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

Review 3.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 4.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

Review 5.  Deregulation of autophagy and vesicle trafficking in Parkinson's disease.

Authors:  Patricia Sheehan; Zhenyu Yue
Journal:  Neurosci Lett       Date:  2018-04-05       Impact factor: 3.046

Review 6.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 7.  Biomarkers of Parkinson's disease: 20 years later.

Authors:  Rezzak Yilmaz; Franziska Hopfner; Thilo van Eimeren; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2019-04-04       Impact factor: 3.575

8.  Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats.

Authors:  Camila Hillesheim Horst; Franciele Schlemmer; Natália de Aguiar Montenegro; Ana Carolina Martins Domingues; Gabriel Ginani Ferreira; Cínthia Yara da Silva Ribeiro; Rafael Rocha de Andrade; Elaine Del Bel Guimarães; Simoneide Souza Titze-de-Almeida; Ricardo Titze-de-Almeida
Journal:  Neurochem Res       Date:  2018-09-28       Impact factor: 3.996

9.  Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.

Authors:  Konrad M Ricke; Thomas Paß; Sammy Kimoloi; Kai Fährmann; Christian Jüngst; Astrid Schauss; Olivier R Baris; Marijana Aradjanski; Aleksandra Trifunovic; Therese M Eriksson Faelker; Matteo Bergami; Rudolf J Wiesner
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

Review 10.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.